1. Japan Stocks

  2. •

    Consumer Defensive

  3. •

    Household & Personal Products
Genky DrugStores Co., Ltd.

Genky DrugStores Co., Ltd.

9267.T
Genky DrugStores Co., Ltd.JP flagTokyo Stock Exchange
3,805.00
JPY
-90.00
- -
115.97BMarket Cap
Genky DrugStores Co., Ltd.
9267.T
(Tokyo Stock Exchange)

Recent

price

3,805.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
1,662.65
1,875.94
2,062.28
1,983.05
1,048.54
2,260.78
2,608.52
2,956.98
3,141.9
3,364.32
4,071.98
4,690.45
5,093.66
5,567.39
6,086.29
6,606.96
3,057.73
Revenue per Share
26.45
32.93
41.62
22.61
21.19
63.06
67.48
100.9
103.27
87.35
90.76
159.17
145.59
156.89
208.21
232.51
106.55
Basic EPS, GAAP
-1.63
19.72
-34.65
-100.06
21.34
-58.04
-176.25
-43.04
2.49
-207.97
-118.42
102.81
-145.92
-38.04
92.68
-82.59
- -
Free Cash Flow per Basic Share
4.34
5.29
6.23
6.25
3.13
6.88
7.53
8.73
12.21
12.52
12.5
12.5
12.48
12.48
12.51
13
- -
Dividend per Share
209.39
216.78
252.16
267.9
151.91
357.91
414.93
506.65
561.73
624.05
713.16
872.34
1,005.93
1,150.2
1,346.12
1,565.28
1,447.28
Book Value per Share
237.98
243.69
280.43
293.88
165.01
381.17
437.76
529.11
779.61
810.13
902.07
1,046.71
1,181.13
1,327.71
1,524.4
1,747.94
1,627.76
Tangible Book Value per Share
25
27
27
28
55
28
28
28
30
31
30
30
30
30
30
30
30
Basic Weighted Avg Shares
41,248
51,517
56,701
54,656
57,950
63,144
73,496
83,400
94,869
103,897
123,603
142,376
154,639
169,059
184,860
200,786
92,893
Sales/Revenue/Turnover
2.34
2.62
3.39
1.64
3.28
4.34
3.61
4.62
4.35
3.9
3.51
4.42
3.67
3.97
4.88
4.81
4.98
Operating Margin (%)
869
1,040
1,173
1,356
1,454
1,553
2,189
2,614
2,910
3,320
3,761
4,059
4,592
4,955
5,566
6,292
- -
Depreciation Expense
656
904
1,144
623
1,171
1,761
1,901
2,846
3,118
2,698
2,755
4,832
4,420
4,764
6,324
7,066
3,237
Net Income, GAAP
43.42
43.56
44.37
38.72
41.27
38.02
33.68
30.42
28.14
30.59
31.67
27.48
27.34
28.92
28.15
28.64
25.79
Effective Tax Rate (%)
1.59
1.76
2.02
1.14
2.02
2.79
2.59
3.41
3.29
2.6
2.23
3.39
2.86
2.82
3.42
3.52
3.48
Profit Margin (%)
-2,465
-3,009
-1,817
-1,380
-2,160
-4,663
-6,083
-5,631
-4,779
-2,946
319
-2,501
-6,133
-5,703
-3,512
-2,602
-328
Working Capital
2,973
3,171
4,410
7,304
6,775
7,867
10,896
13,210
8,738
16,036
24,422
21,710
20,762
21,093
22,553
25,956
24,988
LT Debt
6,024
6,797
7,785
8,244
9,270
10,894
12,584
15,178
23,805
25,310
27,686
32,166
36,232
40,680
46,679
53,427
49,792
Total Equity
5.19
6.47
8.04
3.39
5.88
7.87
6.58
8.19
8.05
6.47
5.53
7.55
6.34
6.71
8.45
8.17
4.27
Return on Invested Capital (%)
7.24
9
9.88
4.39
6.89
9.08
7.73
9.3
9.78
7.57
5.99
9.1
7.66
7.48
9.22
9.41
4.5
Return on Capital (%)
13.62
16.22
17.76
8.7
14.84
19.15
17.53
21.91
19.96
14.89
13.47
20.08
15.5
14.55
16.68
15.98
7.91
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'24
Sep'25
Dec'25
ST Debt
8,095
- -
7,914
LT Borrowings
22,408
- -
24,988
LT Finance Leases
145
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
30
- -
30
Market Capitalization
87,535
113,772
94,937

Working Capital

FRC

•

in mil. unless spec.
Jun'24
Sep'25
Dec'25
Total Current Assets
37,334
- -
40,734
Cash, Cash Equivalents & STI
5,896
- -
6,943
Accounts Receivable, Net
4,685
- -
3,938
Inventories
24,028
- -
26,744
Total Current Liabilities
40,846
- -
41,062
Payables & Accruals
- -
- -
- -
ST Debt
8,095
- -
7,914
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
17.9%
14.06%
14.46%
Free Cash Flow
-970.04%
-207.12%
-189.17%
Net Income, GAAP
17.5%
23.82%
11.73%
Sales/Revenue/Turnover
12.32%
10.22%
8.62%
Total Cash Common Dividend
- -
- -
3.95%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
46,871
45,096
44,620
48,273
184,860
2025
- -
- -
- -
- -
200,786
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
47.54
- -
- -
- -
208.21
2025
- -
- -
- -
- -
232.51
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
12.51
2025
- -
- -
- -
- -
13
2026
- -
- -
- -
- -
- -
Similar Companies
McPherson's Limited (MCP.AX)
Kao Corporation (4452.T)
Helen of Troy Limited (HELE)
Winning Brands Corporation (WNBD)
Milbon Co., Ltd. (MIOFF)
Cupid Limited (CUPID.BO)
Business
Genky DrugStores Co., Ltd. (9267.T) operates as a holding company overseeing a chain of discount drugstores in Japan that retail medicines, over-the-counter drugs, cosmetics, miscellaneous goods, health and wellness supplements, personal care products, household items, and food products; the company emphasizes private-label brands, which account for about 30% of sales and offer discounts relative to national brands, alongside prescription medications and pharmaceutical consultation services. Founded in 1988 and headquartered at 38-33 Shimokumeda, Maruoka-cho, Sakai City, Fukui Prefecture, Japan, Genky DrugStores manages approximately 1,841 employees and focuses on rural and declining markets with stores averaging 1,000 square meters, providing one-stop shopping for daily necessities where food represents roughly 70% of sales. The company vertically integrates store development, logistics, and real estate acquisition to support operational efficiency; it serves general consumers through an expanding network, reporting net sales of 200.8 billion yen for the fiscal year ended June 2025, with all-store sales growth of 9.1% in November 2025 and existing store sales up 2.2%. In recent developments, Genky DrugStores opened 54 new stores in the last fiscal year and targets 66 additional stores with 10% overall growth in fiscal 2026; it transitioned to a pure holding company structure in December 2017, enabling focused group management of its operating subsidiary while driving consistent revenue expansion outpacing Japan's retail averages at 9.5% annually.